We hope to see you again soon!

You are now leaving Lundbeck UK's website (www.lundbeck.com/uk) for an external website. External links are provided as a resource to the viewer. Lundbeck UK are not responsible for the external website and its content.

UK-NOTPR-1010 | April 2022

Continue

Cancel

Press

Media relations

Lundbeck seeks an open and active dialogue with the press. Members of the press are always welcome to direct enquiries to our press contacts who work to handle them quickly and professionally.

We are always available to take your enquiries.

For UK general enquiries, please call us +44 1908 649966, or email us at united_kingdom@lundbeck.com.

About Lundbeck

Lundbeck is a global pharmaceutical company specialising in neurological and psychiatric disorders. For more than 70 years, we have been at the forefront of neuroscience research. We are dedicated to advancing brain health and transforming lives.

 

More than 3 billion people worldwide are living with a neurological condition.1 At Lundbeck, every day, we strive for improved treatment and a better life for people living with brain diseases.

 

We have approximately 5,500 employees in more than 50 countries who are engaged in the entire value chain throughout research, development, production, marketing and sales.

 

Our pipeline consists of several Research and Development programmes and our products are available in more than 100 countries. We have research centres in Denmark and the US and our production facilities are located in Denmark, France and Italy. Lundbeck generated revenue of DKK 22 billion in 2024.

 

Visit us on Instagram at @LundbeckUK and via our LundbeckUK LinkedIn page to learn more about the work we do in the UK and our focus on brain diseases.

 

Facts about Lundbeck

70+ years

In the forefront of neuroscience research

100+

Countries of operation around the world

+5,500

Employees worldwide

22b DKK

Of revenue generated in 2024

  1. Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Steinmetz, Jaimie D et al. The Lancet Neurology, Volume 23, Issue 4, 344 - 381.

UK-NOTPR-2564 | July 2025